169 related articles for article (PubMed ID: 32957990)
1. Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review.
Cooper JT; Lloyd A; Sanchez JJG; Sörstadius E; Briggs A; McFarlane P
Health Qual Life Outcomes; 2020 Sep; 18(1):310. PubMed ID: 32957990
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey.
Kularatna S; Senanayake S; Gunawardena N; Graves N
BMJ Open; 2019 Feb; 9(2):e024854. PubMed ID: 30772857
[TBL] [Abstract][Full Text] [Related]
3. Quality of life of young adults and adolescents with chronic kidney disease.
Tong A; Wong G; McTaggart S; Henning P; Mackie F; Carroll RP; Howard K; Craig JC
J Pediatr; 2013 Oct; 163(4):1179-85.e5. PubMed ID: 23800404
[TBL] [Abstract][Full Text] [Related]
4. Health state utility instruments compared: inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D.
Gamst-Klaussen T; Chen G; Lamu AN; Olsen JA
Qual Life Res; 2016 Jul; 25(7):1667-78. PubMed ID: 26687615
[TBL] [Abstract][Full Text] [Related]
5. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.
Kennedy-Martin M; Slaap B; Herdman M; van Reenen M; Kennedy-Martin T; Greiner W; Busschbach J; Boye KS
Eur J Health Econ; 2020 Nov; 21(8):1245-1257. PubMed ID: 32514643
[TBL] [Abstract][Full Text] [Related]
6. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments.
Wyld M; Morton RL; Hayen A; Howard K; Webster AC
PLoS Med; 2012; 9(9):e1001307. PubMed ID: 22984353
[TBL] [Abstract][Full Text] [Related]
8. Estimation of population-based utility weights for health states of chronic kidney disease, dialysis and kidney transplantation.
Jo MW; Lee HJ; Ryu DR; Park J; Ock M; Kim SH
Nephrology (Carlton); 2020 Jul; 25(7):544-550. PubMed ID: 32026549
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.
Reilly R; Evans K; Gomersall J; Gorham G; Peters MD; Warren S; O'Shea R; Cass A; Brown A
BMC Health Serv Res; 2016 Apr; 16():119. PubMed ID: 27048280
[TBL] [Abstract][Full Text] [Related]
10. Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.
Rajan M; Lai KC; Tseng CL; Qian S; Selim A; Kazis L; Pogach L; Sinha A
Qual Life Res; 2013 Feb; 22(1):53-64. PubMed ID: 22392523
[TBL] [Abstract][Full Text] [Related]
11. Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis.
Wong MG; Ninomiya T; Liyanage T; Sukkar L; Hirakawa Y; Wang Y; Wyld MLR; Morton RL; Chadban S; Howard K; Jardine MJ
Nephrology (Carlton); 2019 Jun; 24(6):605-614. PubMed ID: 30039893
[TBL] [Abstract][Full Text] [Related]
12. Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.
Jesky MD; Dutton M; Dasgupta I; Yadav P; Ng KP; Fenton A; Kyte D; Ferro CJ; Calvert M; Cockwell P; Stringer SJ
PLoS One; 2016; 11(11):e0165675. PubMed ID: 27832126
[TBL] [Abstract][Full Text] [Related]
13. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
[TBL] [Abstract][Full Text] [Related]
14. Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression.
Dickerson JF; Feeny DH; Clarke GN; MacMillan AL; Lynch FL
Qual Life Res; 2018 Feb; 27(2):447-454. PubMed ID: 29149441
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life and estimates of utility in chronic kidney disease.
Gorodetskaya I; Zenios S; McCulloch CE; Bostrom A; Hsu CY; Bindman AB; Go AS; Chertow GM
Kidney Int; 2005 Dec; 68(6):2801-8. PubMed ID: 16316356
[TBL] [Abstract][Full Text] [Related]
16. A systematic literature review of health state utility values in head and neck cancer.
Meregaglia M; Cairns J
Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
[TBL] [Abstract][Full Text] [Related]
17. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design.
Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM
Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.
Kularatna S; Byrnes J; Chan YK; Ski CF; Carrington M; Thompson D; Stewart S; Scuffham PA
Qual Life Res; 2017 Dec; 26(12):3399-3408. PubMed ID: 28766084
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis.
Stawowczyk E; Kawalec P
Pharmacoeconomics; 2018 Apr; 36(4):419-434. PubMed ID: 29260508
[TBL] [Abstract][Full Text] [Related]
20. Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors.
Hosseini K; Omorou AY; Hubert J; Ngueyon Sime W; Ladrière M; Guillemin F
Value Health; 2017 Dec; 20(10):1376-1382. PubMed ID: 29241897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
